University of Massachusetts Medical School Faculty Publications


The state and consequences of dermatology drug prices in the United States

UMMS Affiliation

Division of Dermatology, Department of Medicine

Publication Date


Document Type



Dermatology | Pharmacoeconomics and Pharmaceutical Economics


In 2014, Medicare expenditures increased 12%, the largest increase reported since 2002, resulting in major concerns by both patients and physicians. Although costs are rising for both specialty drugs and generic medications,out-of-pocket costs, restrictive formularies,and health plan bureaucracies are limiting patients' access to necessary medications. In response, the Regulatory Policy Committee of the American Academy of Dermatology (AAD)/Association (AAD/A) convened a Task Force on Drug Pricing and Transparency. This editorial summarizes the issues addressed by the task force along with relevant AAD/A policy.


coinsurances, drug pricing, formulary tiering, generic drugs, out-of-pocket costs, pharmacy benefit managers, prior authorizations

Rights and Permissions

Citation: J Am Acad Dermatol. 2016 Sep;75(3):603-5. doi: 10.1016/j.jaad.2016.03.053. Epub 2016 Jul 13. Link to article on publisher's site


Full author list omitted for brevity. For full list of authors see article.

Related Resources

Link to Article in PubMed

Journal/Book/Conference Title

Journal of the American Academy of Dermatology

PubMed ID